Cardioprotective Effects of 20(S)-Ginsenoside Rh2 against Doxorubicin-Induced Cardiotoxicity In Vitro and In Vivo

Doxorubicin (DOX) is considered as one of the best antineoplastic agents. However, its clinical use is restricted by its associated cardiotoxicity, which is mediated by the production of reactive oxygen species. In this study, 20(S)-ginsenoside Rh2 (Rh2) was explored whether it had protective effect...

Descripción completa

Detalles Bibliográficos
Autores principales: Wang, Hongbo, Yu, Pengfei, Gou, Haitao, Zhang, Jianqiao, Zhu, Mei, Wang, Zhen-hua, Tian, Jing-wei, Jiang, Yong-tao, Fu, Feng-hua
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Hindawi Publishing Corporation 2012
Materias:
Research Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3483725/
https://www.ncbi.nlm.nih.gov/pubmed/23125868
http://dx.doi.org/10.1155/2012/506214

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3483725/
https://www.ncbi.nlm.nih.gov/pubmed/23125868
http://dx.doi.org/10.1155/2012/506214

Ejemplares similares